[Fixed combination of latanoprost and timolol in the long-term treatment of patients with normal-tension glaucoma]. / Fiksirovannaya kombinatsiya latanoprost/timolol v dolgosrochnom lechenii patsientov s glaukomoi normal'nogo davleniya.
Vestn Oftalmol
; 138(3): 82-86, 2022.
Article
em Ru
| MEDLINE
| ID: mdl-35801885
ABSTRACT
The most well-studied and widely prescribed fixed-combination drug for open-angle glaucoma is latanoprost/timolol. Its significant hypotensive effect is especially important in challenging cases, among which are patients with normal-tension glaucoma. With long life expectancy and the constant need for treatment, requirements are high for both the effectiveness of the drug and its tolerability. This paper presents a follow-up of 7 patients with normal-tension glaucoma who have been using the fixed combination of latanoprost/timolol for 10 years. All patients showed very good tolerability to the drug and their quality of life was preserved. A moderate rate of disease progression according to static perimetry was noted in one case. A mild degree of dry eye syndrome according to the OSDI questionnaire and an objective assessment of the state of the ocular surface was observed in one patient. The latanoprost/timolol fixed combination is a well-tolerated, highly effective and safe long-term treatment choice for normal-tension glaucoma.
Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Prostaglandinas F Sintéticas
/
Glaucoma de Ângulo Aberto
/
Hipertensão Ocular
/
Glaucoma de Baixa Tensão
Tipo de estudo:
Diagnostic_studies
Limite:
Humans
Idioma:
Ru
Revista:
Vestn Oftalmol
Ano de publicação:
2022
Tipo de documento:
Article
País de afiliação:
Federação Russa